AstraZeneca (AZN.US) CEO hints at foray into cancer vaccines: years of accumulated mRNA technology, more news expected within months.

Zhitong Finance APP has learned that AstraZeneca (AZN.US) is considering developing cancer vaccines, entering one of the hottest areas in oncology researchalthough questions remain about the scope of application of the technology.